Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense
- PMID: 112062
- PMCID: PMC414399
- DOI: 10.1128/iai.24.3.948-952.1979
Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense
Abstract
Quantitative techniques were used to determine the relative concentrations of viable bacteria and polymorphonuclear leukocytes (PMNs) in the corneas of neutropenic and non-neutropenic guinea pigs with experimental bacterial keratitis induced with three strains of Pseudomonas aeruginosa. Neutropenia was produced by whole-body X-irradiation 1 week before infection. Significantly greater numbers of bacteria were present in the cornea of neutropenic animals 48 h after infection than were present in the corneas of non-neutropenic animals. The same was true 24 and 48 h after infecting animals with Staphylococcus aureus. Examination of histological sections showed that fewer PMNs were present in the corneas of infected neutropenic animals than in the corneas of infected non-neutropenic animals. Radiolabeling of PMNs confirmed a significant reduction in PMN concentration in the corneas of infected neutropenic animals. Tears and the corneal epithelium appear to be the most important elements protecting the cornea against local invasion by bacteria. However, once bacterial keratitis is established, PMNs play a role in limiting bacterial multiplication.
Similar articles
-
Pharmacokinetic considerations in the treatment of bacterial keratitis.Clin Pharmacokinet. 1994 Aug;27(2):129-49. doi: 10.2165/00003088-199427020-00005. Clin Pharmacokinet. 1994. PMID: 7955776 Review.
-
The role of the polymorphonuclear leukocyte in the induction of corneal edema.Invest Ophthalmol Vis Sci. 1986 Oct;27(10):1466-9. Invest Ophthalmol Vis Sci. 1986. PMID: 3759365
-
Experimental bacterial keratitis: a quantitative model of leukocyte migration following transfusion.Exp Hematol. 1981 May;9(5):505-12. Exp Hematol. 1981. PMID: 7238659
-
Polymorphonuclear leukocyte kinetics in experimentally induced keratitis.Arch Ophthalmol. 1985 Feb;103(2):270-4. doi: 10.1001/archopht.1985.01050020122034. Arch Ophthalmol. 1985. PMID: 3977698
-
Corneal response to Pseudomonas aeruginosa infection.Prog Retin Eye Res. 2004 Jan;23(1):1-30. doi: 10.1016/j.preteyeres.2003.10.002. Prog Retin Eye Res. 2004. PMID: 14766315 Review.
Cited by
-
High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.J Immunol. 2015 Feb 15;194(4):1776-87. doi: 10.4049/jimmunol.1401684. Epub 2015 Jan 14. J Immunol. 2015. PMID: 25589066 Free PMC article.
-
Role of neutrophils, MyD88-mediated neutrophil recruitment, and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis.Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2085-93. doi: 10.1167/iovs.09-4139. Epub 2009 Nov 5. Invest Ophthalmol Vis Sci. 2010. PMID: 19892865 Free PMC article.
-
Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis.Antimicrob Agents Chemother. 2004 Jun;48(6):1948-52. doi: 10.1128/AAC.48.6.1948-1952.2004. Antimicrob Agents Chemother. 2004. PMID: 15155183 Free PMC article.
-
Pharmacokinetic considerations in the treatment of bacterial keratitis.Clin Pharmacokinet. 1994 Aug;27(2):129-49. doi: 10.2165/00003088-199427020-00005. Clin Pharmacokinet. 1994. PMID: 7955776 Review.
-
The protective role of topical propolis on experimental keratitis via nitric oxide levels in rabbits.Mol Cell Biochem. 2006 Jan;281(1-2):153-61. doi: 10.1007/s11010-006-0720-4. Mol Cell Biochem. 2006. PMID: 16328968
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources